8-K - Lantern Pharma Inc. | StockGist

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),

Regulation Fd

9.01

Financial Statements and Exhibits. (d) Exhibits . Exhibit No. Exhibit Description 99.1 Presentation relating to January 22, 2026 event hosted by the Company to

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1